Evaluation of the Clinical Efficacy of Tissue-Engineered Grafts in Urethral Reconstruction: A Systematic Review and Meta-Analysis

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 103

فایل این مقاله در 23 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TUMS-8-3_005

تاریخ نمایه سازی: 17 مهر 1405

چکیده مقاله:

Introduction: The principal purpose of this study was to investigate the clinical outcomes of urethral reconstruction using tissue-engineered grafts.Methods: We searched PubMed/MEDLINE, Scopus, Embase and Web of Science until January ۱st, ۲۰۲۶. Considering the eligibility criteria, two researchers selected the articles independently. We collected data on the patient demographic data and study characteristics. We used STATA version ۱۷.۰ and R version ۴.۳.۳ to reach pooled measures. In order to assess heterogeneity between studies, I۲ were used. In order to look for the source of the statistical heterogeneity we implemented meta-regression analysis and sensitivity analysis was used to check the robustness of the results.Results: We found ۶۳۵ studies which ۷۳ of them were potentially relevant. six articles that met the inclusion criteria was added in the review. The pooled success rate of tissue-engineered urethroplasty was ۰.۷۱ (۹۵% CI: ۰.۶۵–۰.۷۷; P-value< ۰.۰۰۱, with no significant heterogeneity (I²=۰.۰%). The pooled mean postoperative Qmax was ۲۱.۱۴ mL/s (۹۵% CI: ۱۸.۶۷–۲۳.۶۲; v P-value<۰.۰۰۱), with substantial heterogeneity (I²=۷۴.۹۱%). The pooled mean improvement in Qmax was ۱۴.۸۱ mL/s (۹۵% CI: ۱۳.۲۹–۱۶.۳۲; P-value<۰.۰۰۱), with moderate heterogeneity (I²=۵۶.۲۱%). Meta-regression analyses showed that median age, follow-up duration, and stricture length were not significantly associated with the pooled outcomes. All included studies were had overall critical risk of bias. Egger’s test suggested potential publication bias for the success rate (P-value=۰.۰۲), but not for postoperative Qmax (P-value=۰.۴۴۸) or Qmax change (P-value=۰.۶۲۲). Sensitivity analysis confirmed the robustness of our findings.Conclusion: Preliminary evidence suggests that tissue-engineered grafts for urethroplasty are feasible and may provide functional improvement in selected patients. However, all included studies were small and without control groups which substantially limits the certainty and generalizability of our findings. Well-designed comparative trials with standardized outcome reporting are required before the clinical role of tissue-engineered grafts can be clearly defined.

نویسندگان

- -

Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

- -

Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cabral JD, Alkassis M, Khalafalla K, Mahdi M, Hyman MJ, ...
  • Guo Y, Ma N, Zhang J, Chen S, Liu P, ...
  • Barbagli G, Heidenreich A, Zugor V, Karapanos L, Lazzeri M. ...
  • Chen F, Yoo JJ, Atala A. Acellular collagen matrix as ...
  • El-Kassaby AW, Retik AB, Yoo JJ, Atala A. Urethral stricture ...
  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, ...
  • Anzures‐Cabrera J, Higgins JP. Graphical displays for meta‐analysis: an overview ...
  • Bhargava S, Patterson JM, Inman RD, MacNeil S, Chapple CR. ...
  • Karapanos L, Akbarov I, Zugor V, Kokx R, Hagemeier A, ...
  • Choudhury S, Khare E, Pal DK. Acellular Tissue Engineered Pericardial ...
  • Mandal TK, Dhanuka S, Choudhury S, Mukhopadhyay BC, Kayal A, ...
  • Ram-Liebig G, Barbagli G, Heidenreich A, Fahlenkamp D, Romano G, ...
  • Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E, Soker S, ...
  • Atala A. Regenerative bladder augmentation using autologous tissue—when will we ...
  • Jin Y, Yang M, Zhao W, Liu M, Fang W, ...
  • Ortac M, Ekerhult TO, Zhao W, Atala A. Tissue engineering ...
  • Castiglione F, Dewulf K, Hakim L, Weyne E, Montorsi F, ...
  • Chan YY, Bury MI, Yura EM, Hofer MD, Cheng EY, ...
  • Versteegden LR, de Jonge PK, IntHout J, van Kuppevelt TH, ...
  • نمایش کامل مراجع